查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1928549

植物來源生元纖維市場按產品類型、原料來源、形態、應用、最終用戶和分銷管道分類，全球預測（2026-2032年）

Plant-Derived Prebiotic Fiber Market by Product Type, Source, Form, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，植物來源益生元紡織品市場價值將達到 6.8321 億美元，到 2026 年將成長至 7.3348 億美元，到 2032 年將達到 10.1812 億美元，複合年成長率為 5.86%。

關鍵市場統計數據
基準年 2025 6.8321億美元
預計年份：2026年 7.3348億美元
預測年份 2032 10.1812億美元
複合年成長率 (%) 5.86%

本書以清晰易懂的科學視角，介紹了植物來源益生元纖維，重點闡述了正在重塑配方選擇的科學原理、供應和商業性因素。

植物來源生元纖維融合了營養科學、永續採購和成分創新，正在重塑食品、飲料、膳食補充劑、動物飼料和藥物製劑等領域的產品開發。分析方法和萃取技術的進步，使生產者能夠生產出具有特定分子特徵的高效功能性纖維，從而支持腸道健康、血糖值調節和消化器官系統健康。這些特性滿足了消費者對潔淨標示、科學功效和可追溯性的需求，同時，明確健康聲明和標籤要求的法規結構也在不斷發展和改進。

萃取創新、經證實的功效和永續性採購如何從根本上重新定義該產業的競爭優勢

近年來，植物來源生元纖維領域經歷了變革性的轉變，其意義遠不止於產品本身的逐步改進，而是涵蓋了供應鏈結構、配方技術和商業化等方面的根本性變革。萃取和純化技術的進步使得高純度組成和新型基質的製備成為可能，從而能夠精準靶向微生物群落和宿主反應。同時，消費者對潔淨標示、低加工成分的需求日益成長，促使供應商更加重視原料來源的檢驗，並減少合成加工助劑的使用。這種功能特性更加清晰、來源更可靠的趨勢，正推動價值提案從商品定價轉向基於性能和品牌故事的差異化。

對受2025年後關稅變化影響的整個產業的策略採購、配方調整和供應鏈韌性措施進行詳細分析

美國關稅於2025年生效，其累積影響波及植物來源生元纖維的籌資策略、定價及供應商關係。依賴進口的製造商被迫重新評估其供應商組合，並尋求在地採購方案，以降低成本波動和貿易摩擦的風險。因此，採購部門加快了國內及周邊供應商的資質認證，一些配方師也調整了產品規格，以採用功能特性相近的植物性替代成分。在無法進行替代的情況下，企業要么暫時承擔更高的原料成本，要么透過談判簽訂長期合約來穩定價格並確保供應的持續性。

多面向細分分析揭示了產品類型、原料來源、應用領域、最終用戶、分銷管道和產品形式如何驅動差異化的價值提案。

細分市場分析揭示了產品類型、應用、原料來源、最終用戶、分銷管道和劑型等不同的價值促進因素，這些因素共同塑造了商業策略。依產品類型分類，我們檢視了寡果醣、半乳寡糖、菊糖、果膠和抗性糊精。每類產品都有不同的溶解性、甜度和發酵特性，這些特性會影響配方和劑量。按應用分類，我們分析了飼料、營養保健品、食品飲料和製藥市場。每種應用都有其獨特的法規要求、穩定性要求和效能限制，這些因素會影響供應商的選擇和規格要求。按成分分類，我們分析了香蕉、菊苣根、大蒜、菊芋和洋蔥的市場，重點關注植物來源成分對感官屬性、輔助營養素基質和永續性敘事的影響，這些在品牌故事中日益重要。

區域觀點著重分析美洲、歐洲、中東和非洲以及亞太地區的獨特需求模式、法規環境和關鍵採購挑戰。

區域趨勢正在重塑供需格局，這要求企業採取差異化的市場進入、採購和商業化策略。在美洲，消費者對腸道健康的日益關注、成熟的膳食補充劑體係以及對生產能力的持續投資，共同支撐了對經臨床檢驗的成分和高階配方的需求。同時，北美和拉丁美洲的供應鏈各自擁有獨特的採購機會和物流考量，必須兼顧監管標籤標準和貿易政策趨勢。

企業策略和競爭動態凸顯了創新、垂直整合和科學信譽如何創造持久的差異化優勢。

公司層面的發展趨勢取決於產品創新、供應鏈整合和市場進入柔軟性的綜合考量。領先的原料生產商正投資於先進的分餾技術、臨床試驗項目以及學術合作夥伴關係，以增強產品功效並打造差異化的產品規格。同時，一些公司正尋求垂直整合，將上游工程的種植、提取和純化能力納入公司內部，以控制利潤率並提高可追溯性；而另一些公司則選擇策略聯盟和契約製造協議，以保持靈活性並降低資本支出。

為平衡供應多元化、臨床投資、永續性和通路特定產品設計，提供切實可行的策略建議

產業領導者應採取以組合為導向的方法，同時應對供應風險、證據產生和市場管道最佳化。首先，應實現植物原料來源和合格管道的多元化，以減少對單一來源的依賴，並在不影響功能性能的前提下實現快速替代。這應與供應商發展計劃和多年期合約相結合，以推動品質改進和產能投資。其次，應優先進行針對高價值應用（例如嬰幼兒營養品和藥品補充劑）的臨床和作用機制研究，以確保其功效聲明的可靠性和高階定位。合作試驗和真實世界證據研究可以加速產品接受度，並減少商業化阻力。

為了支持這些建議，我們採用了一種透明且可重複的調查方法：結合了初步訪談、文獻綜合、細分映射和專家檢驗。

本分析採用的調查方法結合了定性和定量技術，以確保獲得可靠且可操作的見解。主要研究包括對行業高管、配方科學家、採購人員和通路合作夥伴進行結構化訪談，以收集有關採購限制、應用需求和商業化策略的第一手資訊。次要研究包括仔細審查同行評審期刊、監管建議、專利趨勢和公開資訊，檢驗技術聲明並確定創新路徑。數據三角驗證確保研究結果既反映了市場實踐，也反映了益生元功能的最新科學認知。

一份簡明扼要、全面全面的分析報告，重點闡述了科學證據、供應鏈韌性和商業性導向相結合對於確保長期競爭優勢的重要性。

總之，植物來源生元纖維正處於策略轉折點，科學嚴謹性、供應鏈韌性和商業性創新將決定市場走向。該產業正從以大宗商品主導的動態轉型為基於臨床證據、來源透明度和特定應用效能的差異化提案。隨著貿易措施和區域動態的變化，那些積極拓展供應來源、優先考慮高價值臨床證據並最佳化產品形式以適應通路需求的企業，將保持戰略選擇權並抓住高階市場機會。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章植物來源益生元纖維市場（依產品類型分類）

  • 寡果醣
  • 半乳寡糖
  • 菊糖
  • 果膠
  • 抗性糊精

第9章植物來源益生元纖維市場（依來源分類）

  • 香蕉
  • 菊苣根
  • 蒜
  • 菊芋
  • 洋蔥

第10章植物來源生元纖維市場（按類型分類）

  • 膠囊
  • 液體
  • 粉末

第11章植物來源益生元纖維市場（依應用領域分類）

  • 動物飼料
  • 營養補充品
  • 食品/飲料
  • 製藥

第12章植物來源益生元纖維市場（以最終用戶分類）

  • 畜牧業
  • 機能性食品
  • 嬰兒奶粉
  • 運動營養

第13章植物來源益生元纖維市場（依通路分類）

  • 離線
    • 便利商店
    • 專賣店
    • 超級市場和大賣場
  • 線上
    • 廠商直銷網站
    • 電子商務平台

第14章 各地區植物來源生元纖維市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章植物來源益生元纖維市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國植物來源生元纖維市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國植物來源生元纖維市場

第18章：中國植物來源生元纖維市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Baolingbao Biology Co., Ltd.
  • Beneo GmbH
  • Biofeed Technology, Inc.
  • Cargill, Incorporated
  • Cosucra Groupe Warcoing SA
  • DuPont de Nemours, Inc.
  • FrieslandCampina Ingredients BV
  • FUBON Precison Co., Ltd.
  • Guangdong VTR Bio-Tech Co., Ltd.
  • Ingredion Incorporated
  • Kerry Group plc
  • Lallemand Inc.
  • Matrix Nutrition Inc.
  • New Francisco Biotechnology Corporation
  • Nissin Sugar Manufacturing Co., Ltd.
  • Orffa Additives BV
  • Quantum Hi-Tech（Beijing）Biotechnology Co., Ltd.
  • Sensient Technologies Corporation
Product Code: MRR-92740D85F027

The Plant-Derived Prebiotic Fiber Market was valued at USD 683.21 million in 2025 and is projected to grow to USD 733.48 million in 2026, with a CAGR of 5.86%, reaching USD 1,018.12 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 683.21 million
Estimated Year [2026] USD 733.48 million
Forecast Year [2032] USD 1,018.12 million
CAGR (%) 5.86%

A clear, evidence-driven introduction to plant-derived prebiotic fiber highlighting science, supply, and commercial forces reshaping formulation choices

Plant-derived prebiotic fiber represents an intersection of nutrition science, sustainable sourcing, and ingredient innovation that is reshaping product development across food, beverage, dietary supplements, animal feed, and pharmaceutical formulations. Drawing on advances in analytical methods and extraction technology, manufacturers are increasingly able to produce stable, functional fibers with targeted molecular profiles that support gut health, glycemic modulation, and digestive wellness. These attributes are resonating with consumers who prioritize clean labels, evidence-backed benefits, and traceability, while regulatory frameworks continue to evolve to clarify health claims and labeling requirements.

Against this backdrop, the industry is driven by two converging forces: demand for clinically relevant, well-characterized fibers and the need to decouple supply chains from volatile commodity cycles. Consequently, R&D investments are focusing on enhancing functionality, improving sensory profiles, and optimizing dosage formats for diverse applications, while procurement teams are exploring alternative botanical sources and strategic partnerships to secure consistent supply. Moreover, cross-disciplinary collaborations among ingredient manufacturers, academic researchers, and product formulators are accelerating translational science-turning mechanistic insights about microbiome modulation into pragmatic ingredient specifications.

Taken together, these dynamics create both opportunities and responsibilities for stakeholders. Manufacturers must demonstrate robust evidence of functional benefit and ensure scalability of sourcing, whereas brand owners need to balance efficacy claims with clear communication. As the ecosystem evolves, companies that combine rigorous science, transparent sourcing, and application-ready formats will be best positioned to convert scientific credibility into market traction.

How extraction innovations, claim substantiation, and sustainability-driven sourcing are fundamentally redefining competitive advantages in the sector

Recent years have witnessed transformative shifts in the plant-derived prebiotic fiber landscape that extend beyond incremental product improvements to structural changes in supply, formulation, and commercialization. Technological advances in extraction and refinement are enabling higher-purity fractions and novel matrices, which in turn facilitate precise targeting of microbial taxa and host responses. Simultaneously, the industry is responding to intensified consumer demand for clean-label, minimally processed ingredients, prompting suppliers to validate provenance and reduce synthetic processing aids. This combination of better-defined functional profiles and stronger provenance narratives has shifted the value proposition from commodity pricing to performance- and story-driven differentiation.

In parallel, regulatory scrutiny and claim substantiation requirements have raised the bar for evidence, encouraging the adoption of standardized clinical endpoints and biomarker-based validation. As a result, companies are investing more in clinical trials and real-world evidence generation, leading to a more rigorous commercialization pathway for high-value prebiotic ingredients. Furthermore, distribution dynamics are shifting as e-commerce and direct-to-consumer channels exert pressure on traditional retail models; brands are leveraging digital channels to educate consumers about microbiome science and dosages, enabling more targeted positioning.

Finally, strategic sourcing and sustainability goals are reshaping raw-material decisions. Suppliers are exploring underutilized botanical sources and optimizing agricultural practices to enhance yield and traceability while mitigating climate and geopolitical risks. Taken together, these shifts are not merely evolutionary but transformative, creating new competitive vectors for firms that can align scientific credibility, sustainable sourcing, and agile go-to-market execution.

A detailed appraisal of how post-2025 tariff shifts prompted strategic sourcing, reformulation, and supply chain resilience measures across the industry

The cumulative impact of the United States tariffs implemented in 2025 has produced reverberations across procurement strategies, price discovery, and supplier relationships for plant-derived prebiotic fibers. Import-dependent manufacturers were compelled to reassess supplier portfolios and explore localized sourcing as a means to moderate cost volatility and reduce exposure to trade friction. Consequently, procurement teams accelerated qualification of domestic and near-shore suppliers, while some formulators adjusted product specifications to accommodate alternative botanical inputs that offered comparable functional profiles. Where substitution was not feasible, companies absorbed higher input costs temporarily or negotiated longer-term contracts to stabilize pricing and ensure continuity of supply.

In addition, the tariff environment altered route-to-market economics, with distribution channels reassessing inventory strategies and lead times to maintain service levels. Retailers and brand owners faced trade-offs between passing costs to consumers and protecting margin, which in some cases led to reformulation, smaller pack sizes, or value-based tiering. Regulatory and trade compliance functions likewise grew in prominence, as companies sought tariff classification clarity and explored duty mitigation options such as free trade agreements, tariff engineering, and bonded warehousing. These operational adjustments were complemented by increased investment in supply chain transparency initiatives, since improved traceability can support preferential treatment under origin-specific rules.

Importantly, the tariffs catalyzed strategic responses that extended beyond immediate cost considerations. Firms with robust R&D and manufacturing capabilities accelerated vertical integration and contract manufacturing partnerships to capture more of the value chain, while others pursued joint ventures to secure access to critical botanical sources. As a result, the post-2025 landscape is characterized by greater diversification of supply, renewed emphasis on domestic capacity building, and more sophisticated risk-management frameworks that balance cost, quality, and continuity.

A multidimensional segmentation analysis revealing how product type, source, application, end user, distribution channel, and form drive differentiated value propositions

Segmentation insight reveals differentiated value drivers across product types, applications, sources, end users, distribution channels, and forms that collectively shape commercial strategy. Based on Product Type, market is studied across Fructo-Oligosaccharides, Galacto-Oligosaccharides, Inulin, Pectin, and Resistant Dextrin, and each class exhibits distinct solubility, sweetness, and fermentability profiles that influence formulation and dosing. Based on Application, market is studied across Animal Feed, Dietary Supplements, Food And Beverage, and Pharmaceuticals, with each application imposing its own regulatory, stability, and functional-performance constraints that dictate supplier selection and specification requirements. Based on Source, market is studied across Banana, Chicory Root, Garlic, Jerusalem Artichoke, and Onion, illuminating how botanical provenance affects sensory attributes, co-nutrient matrices, and sustainability narratives that are increasingly relevant to brand storytelling.

Further nuance emerges when examining end-user segmentation. Based on End User, market is studied across Animal Husbandry, Functional Food, Infant Formula, and Sports Nutrition, where divergent tolerances for ingredient cost, purity, and clinical support drive distinct purchasing behavior. Distribution dynamics are also critical: Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Convenience Stores, Specialty Stores, and Supermarket And Hypermarket, while the Online is further studied across Direct Manufacturer Websites and E-Commerce Platforms. These channels differ in merchandising requirements, shelf-life constraints, and educational needs, influencing packaging, SKU assortment, and promotional strategy. Finally, delivery format matters: Based on Form, market is studied across Capsules, Liquid, and Powder, each offering trade-offs related to dosage accuracy, consumer convenience, and formulation compatibility.

Taken together, these segmentation lenses enable stakeholders to align product design with end-market imperatives, prioritize clinical evidence for high-value applications, and tailor channel strategies to optimize reach and conversion. Strategic decisions informed by this multi-dimensional segmentation are better positioned to address functional expectations while meeting commercial constraints.

Regional perspectives that illuminate distinct demand patterns, regulatory environments, and sourcing imperatives across the Americas, EMEA, and Asia-Pacific

Regional dynamics are shaping supply and demand patterns in ways that require differentiated strategies for market entry, sourcing, and commercialization. In the Americas, a convergence of consumer interest in gut health, established nutraceutical frameworks, and ongoing investments in manufacturing capacity support demand for clinically validated ingredients and premium formulations. Meanwhile, North American and Latin American supply chains each present unique sourcing opportunities and logistical considerations that must be balanced against regulatory labeling norms and trade policy developments.

Europe, Middle East & Africa presents a heterogeneous landscape where rigorous regulatory environments and high consumer awareness of functional ingredients coexist with divergent agricultural capabilities and trade corridors. In several markets within this region, policymakers and industry stakeholders emphasize sustainability credentials and traceability, which amplifies the importance of provenance and certification schemes. Additionally, regional trade relationships and regulatory harmonization efforts influence cross-border ingredient flows and commercial partnerships.

Asia-Pacific continues to exhibit rapid innovation in application formats and distribution models, driven by a large and diverse consumer base, expanding retail channels, and strong R&D ecosystems. Local botanical sources are important in the region, and manufacturers often prioritize formulations that reflect regional taste preferences and consumption habits. Across all regions, supply chain resilience, value-chain integration, and clinical validation remain common strategic levers, but their prioritization varies based on regional market maturity and consumer expectations.

Corporate strategies and competitive dynamics that highlight how innovation, vertical integration, and scientific credibility create durable differentiation

Company-level dynamics are defined by a mix of product innovation, supply-chain integration, and go-to-market flexibility. Leading ingredient providers are investing in advanced fractionation techniques, clinical programs, and collaborative partnerships with academic institutions to strengthen their efficacy claims and create differentiated product specifications. Parallel to this, some firms are pursuing vertical integration-bringing upstream cultivation, extraction, and refinement capabilities in-house-to improve margin control and traceability, while others prefer strategic alliances or toll-manufacturing agreements to maintain agility and limit capital expenditure.

Competitive positioning also hinges on channel strategies and formulation support. Companies that offer application expertise, co-development services, and turnkey formulations increase their attractiveness to brand owners seeking to shorten time-to-market. In addition, supply agreements that incorporate quality assurance protocols, contingency sourcing plans, and sustainability metrics are becoming standard negotiation elements, reflecting buyers' heightened emphasis on continuity and ethical sourcing. Mergers and collaborations are selectively deployed to access proprietary intellectual property, expand geographic reach, or secure botanical supply.

Finally, non-product assets-such as scientific publications, clinical partnerships, and certifications-serve as tangible differentiators in procurement decisions. Companies that consistently invest in these assets not only elevate their credibility with regulatory bodies and customers but also position themselves to capture premium opportunities in applications demanding rigorous substantiation.

Actionable strategic recommendations that guide leaders to balance supply diversification, clinical investment, sustainability, and channel-specific product design

Industry leaders should adopt a portfolio-oriented approach that simultaneously addresses supply risk, evidence generation, and route-to-market optimization. First, diversify botanical sourcing and qualification pipelines to reduce single-source exposure and enable rapid substitution without compromising functional performance. This should be complemented by supplier development programs and multi-year agreements that incentivize quality improvements and capacity investment. Second, prioritize clinical and mechanistic research targeted at the highest-value applications-such as infant nutrition and pharmaceutical adjuncts-to secure defendable claims and premium positioning. Collaborative trials and real-world evidence studies can accelerate acceptance and reduce commercialization friction.

Third, align packaging and format development with channel-specific needs, ensuring that dosage accuracy, shelf stability, and consumer convenience are optimized for both offline retail environments and direct-to-consumer channels. Fourth, embed sustainability and traceability metrics into procurement and marketing frameworks, using certifications, traceable supply chains, and transparent storytelling to meet evolving consumer and regulatory expectations. Fifth, enhance operational resilience by investing in near-shore capacity, flexible manufacturing contracts, and phased inventory strategies that respond to trade disruptions while preserving service levels.

Lastly, cultivate cross-functional capabilities-linking R&D, regulatory affairs, and commercial teams-to ensure that product specifications, evidence packages, and go-to-market narratives are coherent and compelling. Taken together, these actions create a defensible strategic posture that balances growth ambition with disciplined risk management.

A transparent, reproducible research methodology combining primary interviews, literature synthesis, segmentation mapping, and expert validation to underpin recommendations

The research methodology underpinning the analysis combines qualitative and quantitative techniques to ensure robust, actionable insights. Primary research involved structured interviews with industry executives, formulation scientists, procurement leads, and channel partners to capture firsthand perspectives on sourcing constraints, application requirements, and commercialization strategies. Secondary research encompassed review of peer-reviewed journals, regulatory advisories, patent landscapes, and public disclosures to validate technical assertions and identify innovation trajectories. Data triangulation ensured that findings reflected both market practice and the latest scientific understanding of prebiotic function.

Segmentation mapping was conducted by integrating product-type attributes, application constraints, botanical source characteristics, distribution-channel behaviors, and form-specific considerations to create a multidimensional framework that informs strategic choices. Validation rounds with subject-matter experts refined assumptions and clarified uncertainties, while scenario analysis explored potential responses to trade and regulatory developments. Limitations of the study include variability in proprietary formulation practices and the evolving nature of clinical evidence, both of which were mitigated through sensitivity analyses and expert validation.

Overall, the methodology emphasizes transparency, reproducibility, and a pragmatic orientation toward commercial applicability, ensuring that recommendations are grounded in verifiable inputs and informed judgment rather than conjecture.

A concise synthesis emphasizing the imperative to blend scientific proof, supply resilience, and commercial focus to secure long-term competitive advantage

In conclusion, plant-derived prebiotic fiber is at a strategic inflection point where scientific rigor, supply resilience, and commercial creativity determine market outcomes. The industry is shifting from commodity-driven dynamics toward differentiated propositions grounded in clinical substantiation, provenance transparency, and application-specific performance. As trade measures and regional dynamics evolve, companies that proactively diversify supply, prioritize high-value clinical evidence, and tailor formats to channel requirements will retain strategic optionality and capture premium opportunities.

Moreover, integration of sustainability practices and investment in traceability not only addresses regulatory and consumer expectations but also mitigates supply-chain disruptions and strengthens negotiation positions with large buyers. To succeed, organizations must operationalize cross-functional alignment-ensuring R&D, procurement, regulatory, and commercial teams co-design product offerings that are scientifically defensible, manufacturable at scale, and compelling to end users. The path forward requires disciplined execution, continual learning, and the willingness to invest where differentiation yields measurable returns.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Plant-Derived Prebiotic Fiber Market, by Product Type

  • 8.1. Fructo-Oligosaccharides
  • 8.2. Galacto-Oligosaccharides
  • 8.3. Inulin
  • 8.4. Pectin
  • 8.5. Resistant Dextrin

9. Plant-Derived Prebiotic Fiber Market, by Source

  • 9.1. Banana
  • 9.2. Chicory Root
  • 9.3. Garlic
  • 9.4. Jerusalem Artichoke
  • 9.5. Onion

10. Plant-Derived Prebiotic Fiber Market, by Form

  • 10.1. Capsules
  • 10.2. Liquid
  • 10.3. Powder

11. Plant-Derived Prebiotic Fiber Market, by Application

  • 11.1. Animal Feed
  • 11.2. Dietary Supplements
  • 11.3. Food And Beverage
  • 11.4. Pharmaceuticals

12. Plant-Derived Prebiotic Fiber Market, by End User

  • 12.1. Animal Husbandry
  • 12.2. Functional Food
  • 12.3. Infant Formula
  • 12.4. Sports Nutrition

13. Plant-Derived Prebiotic Fiber Market, by Distribution Channel

  • 13.1. Offline
    • 13.1.1. Convenience Stores
    • 13.1.2. Specialty Stores
    • 13.1.3. Supermarket And Hypermarket
  • 13.2. Online
    • 13.2.1. Direct Manufacturer Websites
    • 13.2.2. E-Commerce Platforms

14. Plant-Derived Prebiotic Fiber Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Plant-Derived Prebiotic Fiber Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Plant-Derived Prebiotic Fiber Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Plant-Derived Prebiotic Fiber Market

18. China Plant-Derived Prebiotic Fiber Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Baolingbao Biology Co., Ltd.
  • 19.6. Beneo GmbH
  • 19.7. Biofeed Technology, Inc.
  • 19.8. Cargill, Incorporated
  • 19.9. Cosucra Groupe Warcoing S.A.
  • 19.10. DuPont de Nemours, Inc.
  • 19.11. FrieslandCampina Ingredients B.V.
  • 19.12. FUBON Precison Co., Ltd.
  • 19.13. Guangdong VTR Bio-Tech Co., Ltd.
  • 19.14. Ingredion Incorporated
  • 19.15. Kerry Group plc
  • 19.16. Lallemand Inc.
  • 19.17. Matrix Nutrition Inc.
  • 19.18. New Francisco Biotechnology Corporation
  • 19.19. Nissin Sugar Manufacturing Co., Ltd.
  • 19.20. Orffa Additives B.V.
  • 19.21. Quantum Hi-Tech (Beijing) Biotechnology Co., Ltd.
  • 19.22. Sensient Technologies Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FRUCTO-OLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FRUCTO-OLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FRUCTO-OLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GALACTO-OLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GALACTO-OLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GALACTO-OLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INULIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INULIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INULIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PECTIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PECTIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PECTIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY RESISTANT DEXTRIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY RESISTANT DEXTRIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY RESISTANT DEXTRIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY BANANA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY BANANA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY BANANA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CHICORY ROOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CHICORY ROOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CHICORY ROOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GARLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GARLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GARLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY JERUSALEM ARTICHOKE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY JERUSALEM ARTICHOKE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY JERUSALEM ARTICHOKE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL HUSBANDRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL HUSBANDRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL HUSBANDRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FUNCTIONAL FOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FUNCTIONAL FOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FUNCTIONAL FOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INFANT FORMULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INFANT FORMULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INFANT FORMULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPORTS NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPORTS NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPORTS NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CONVENIENCE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CONVENIENCE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIRECT MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIRECT MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIRECT MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 221. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)